To further our commitment to improving our customers’ experience, as part of CGHO’s annual product review in February 2025, we wanted to remind you of some significant uplifts we made to our CGHO Gold product. To fully illustrate this value for customers who are uncertain between choosing a Gold or Silver plan, we wanted to outline a few key enhancements that may just tip the scales.

For customers who have purchased the optional International Outpatient module on Gold, we have tripled the coverage from Silver for:

• ‘Consultations and outpatient procedures’ (now $7,500 on Gold)
• ‘Outpatient rehabilitation’ (now $15,000 on Gold)
• ‘Prescribed drugs and dressings’ (now $4,500 on Gold)

We have also doubled our coverage from Silver on hormone therapies, such as for menopause and low testosterone, which for Gold now stands at $2,000.

Those customers who have purchased the optional International Health & Wellbeing module can now enjoy:

• Double the coverage limit of Silver on ‘footcare with a podiatrist or chiropodist’ and ‘bone densitometry’ (now $650 on Gold)

Key Enhancements to our Core (In-Patient) Coverage:

• A 100% increase on ‘cancer-related appliances’: Silver: $125, Gold: $250
• Removal of cost-share on ‘cancer preventative surgeries’: Silver: $10,000, Gold: $18,000
• A 100% increase on ‘hospital accommodation for parent/guardian’: Silver: $1,000, Gold: $2,000
• A 50% increase on ‘inpatient cash benefits’: Silver: $100, Gold: $150

For customers who want that extra layer of security in their health care plan; go for Gold.

Back to homepage